CBD market will grow by over 700% in 2019.
Rule would cost $177 billion through 2029.
Value-based programs emphasize better care, enhanced health, and lower costs.
$10 million to fund Critical Access Pharmacy Program.
Funds to help establish education and training for pharmacy technicians.
DIR abuse might require Presidential and Congressional intervention.
With tight margins, DIR fees, generic effective rate fees, and the delay in receiving third-party reimbursements, it’s easy to find yourself faced with cash flow pressures.
Results from IQVIA Institute for Human Data Science's annual report, "Medicine Use and Spending in the U.S."
Finalized rule is a step toward increasing drug pricing transparency.
Rebates for prescription drugs are under scrutiny and attack in both the political and healthcare arenas. But what will happen if drug rebates go away?